Biotechnology - Therapeutics and Diagnostics
Drug Delivery I Gene Therapy
AaviGen is a pre-clinical stage biotechnology company focused on the development of curative gene therapies for genetic and acquired cardiovascular and cardiopulmonary diseases. Its lead program employs heart-specific recombinant Adeno-Associated Viruses (AAV) to bring therapeutic genes with unprecedented safety and precision to the diseased heart via a simple one-time intravenous injection. In executing on its program, AaviGen builds on the expertise and track
record of its interdisciplinary leadership team. The company brings together leading knowledge in clinical cardiology& pneumology, virology&genetic vector engineering as well as gene therapy medicinal product development.